tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
TSHA is currently covered by 12 analysts with an average price target of $13.06. This is a potential upside of $8.81 (207.29%) from yesterday's end of day stock price of $4.25.
Taysha Gene Therapies's activity chart (see below) currently has 143 price targets and 161 ratings on display. The stock rating distribution of TSHA is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 19.85% with an average time for these price targets to be met of 278.06 days.
Highest price target for TSHA is $19, Lowest price target is $10, average price target is $13.06.
Most recent stock forecast was given by SALVEEN RICHTER from GOLDMAN SACHS on 21-Jul-2026. First documented stock forecast 19-Oct-2020.
Currently out of the existing stock ratings of TSHA, 18 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Oct-2020
$13
$9.04 (228.28%)
3 months 7 days ago
(21-Jul-2026)
1/3 (33.33%)
$7.33 (129.28%)
92
Buy Since 08-Jun-2021
$11
$7.04 (177.78%)
$11
3 months 26 days ago
(02-Jul-2026)
8/16 (50%)
$4.47 (68.45%)
312
Buy Since 15-Jul-2021
$12
$8.04 (203.03%)
$10
3 months 28 days ago
(30-Jun-2026)
8/25 (32%)
$5.19 (76.21%)
662
Buy Since 08-Mar-2022
$15
$11.04 (278.79%)
$12
3 months 28 days ago
(30-Jun-2026)
0/6 (0%)
$8.19 (120.26%)
Buy Since 27-Jun-2024
$14
$7.66 (120.82%)
$5
4 months 5 days ago
(23-Jun-2026)
2/3 (66.67%)
$7.14 (104.08%)
445
What is TSHA (Taysha Gene Therapies) average time for price targets to be met?
Which analyst most recently updated their price target on TSHA (Taysha Gene Therapies)?
Which analyst has the most public recommendations on TSHA (Taysha Gene Therapies)?
Which analyst is the currently most bullish on TSHA (Taysha Gene Therapies)?
Which analyst is the currently most reserved on TSHA (Taysha Gene Therapies)?
